Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Illumina Announces Recipients of Agricultural Greater Good Initiative Grants

Published: Wednesday, January 16, 2013
Last Updated: Wednesday, January 16, 2013
Bookmark and Share
Expanded program focuses on improving food security and furthering agricultural sustainability.

Illumina, Inc. has announced two new grant recipients of its Agricultural Greater Good Initiative at the 21st International Plant and Animal Genome Conference.

The recipients, International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) and Biosciences Eastern and Central Africa - International Livestock Research Institute Hub (BecA-ILRI Hub), are pioneering applications of Illumina technologies to increase crop yields and reduce poverty and hunger.

ICRISAT will use the grant to expand its efforts to improve the productivity of pigeonpea, a staple crop used for food, feed and fuel production in Africa and India.

BecA-ILRI Hub will use the grant to expand its study of genetic resistance to cassava brown streak disease and cassava mosaic disease, both of which have infected large percentages of crops across East Africa where cassava is a major source of nutrition.

“There is nothing more foundationally important to health than food, and Illumina is excited to be involved with organizations working at the forefront of food security,” said Jay Flatley, President and CEO of Illumina. “Collaboration will enable the power of genomics to impact more people and on a global scale.”

“We are very excited to be a part of Illumina’s Agricultural Greater Good Initiative,” said ICRISAT Director General William Dar. “This grant will supplement our USAID-sponsored efforts on pigeonpea improvement through molecular breeding. We are working in collaboration with our national partners such as the Indian Council of Agricultural Research (ICAR) and State Agricultural Universities, as well as with our African partner institutes, to help ensure food security and income generation in developing countries.”

“Collaborations like these between Illumina and the BecA-ILRI Hub are very welcome as they are key contributors towards strengthening agricultural research and capacity development in Africa,” said Dr. Appolinaire Djikeng, interim Director of the BecA-ILRI Hub.

Dr. Djikeng continued, “If we are to bring Africa out from the shadow of poverty and food insecurity, then African scientists must have the tools to conduct research at the same level as other scientists around the world.”

In 2012, Illumina broadened the scope of the Agricultural Greater Good Initiative through engagement with the Bill & Melinda Gates Foundation and Dow AgroSciences, as well as with the Feed the Future Initiative of the United States Agency for International Development (USAID).

“We’re excited about the opportunity to connect advances in sequencing technologies with the needs of millions of families farming small plots of land in sub-Saharan Africa and South Asia,” said Katherine Kahn, Senior Program Officer at the Bill & Melinda Gates Foundation. “Increasing the productivity and resilience of staple crops including cassava and legumes is key to helping small farmers lift themselves out of poverty.”

“Through science, Dow AgroSciences is working to serve the needs of the growing world,” said Gordon Slack, Dow AgroSciences Global Leader, Finance and Public Affairs. “The need for novel solutions to address food insecurity in Africa and other locations is of paramount importance to Dow AgroSciences employees and the agriculture industry as a whole. We are honored to play a part in this vital work.”

Illumina’s Agricultural Greater Good Initiative, launched in 2011, helps to spur critically needed research that will increase the sustainability, productivity and nutritional density of agriculturally important crop and livestock species. Grant recipients receive donations of Illumina reagents to support their projects.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Illumina Files Patent Infringement Suit in the UK Against Premaitha Health
Suit is filed for Infringement of NIPT Patents.
Monday, March 16, 2015
Illumina Revenues Jump 35 Percent
Company’s Third Quarter 2014 Results Announced.
Tuesday, October 21, 2014
Illumina's HiSeq X Ten Sequencing Technology for Population Studies
Next-generation sequencing technologies to be implemented at new High-Throughput Genomics Center for the MENA region.
Tuesday, July 22, 2014
Novogene Acquires an Illumina HiSeq X Ten Sequencing System
First-in-China deal Iincreases Novogene's investment in Illumina's Next-Generation Sequencing technology.
Thursday, February 13, 2014
Illumina Awarded FDA Contract for NGS Technology to Identify Foodborne Pathogens
Agency selects MiSeq® system for program to explore NGS as mechanism to enhance food safety.
Wednesday, September 19, 2012
The Broad Institute Joins the Illumina Genome Network
Partnership expands the network’s capabilities to enable sequencing of previously inaccessible samples.
Tuesday, June 05, 2012
Cold Spring Harbor Laboratory Joins the Illumina Genome Network
Partnership expands access to large-scale whole genome sequencing.
Monday, May 28, 2012
Illumina Comments on Roche’s Unsolicited Tender Offer Extension
Roche to acquire all outstanding shares of Illumina for $44.50 in cash per common share.
Monday, February 27, 2012
Illumina's Board Unanimously Rejects Roche's Unsolicited Tender Offer
Urges stockholders not to tender their shares, company considers offer inadequate.
Wednesday, February 08, 2012
BCCA Joins the Illumina Genome Network
Network expansion making affordable, high quality whole human genome sequencing services accessible world-wide.
Friday, January 20, 2012
Illumina Appoints Marc Stapley as Senior Vice President and CFO
Stapley brings multi-national experience in high-growth and mature industries.
Thursday, January 05, 2012
Illumina and University of Oxford to Sequence 500 Whole Human Genomes for Rare Disease Research
Opportunity to bring personalized medicine to the forefront of healthcare.
Tuesday, January 03, 2012
Illumina Reports Financial Results for Second Quarter 2011
Revenue of $287.5 million, a 36% increase over the $212.0 million reported in the second quarter of 2010.
Wednesday, July 27, 2011
University of Washington Department of Genome Sciences Joins Illumina Genome Network
Network makes affordable, high-quality whole human genome sequencing services more accessible to life sciences researchers.
Friday, July 01, 2011
Illumina Announces Broad Commercialization of two Sequencing-Based Applications for Gene Expression Analysis
New small RNA and gene expression profiling applications utilize Illumina's genome analyzer and Solexa® sequencing technology.
Tuesday, July 24, 2007
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Senor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Investigating ‘Black Box’ of Human Genetics
Investigations into inactive X chromosomes have shown unusual DNA repeat elements are essential for maintaining 3D structure.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!